Net income increased 22.7%
Net income changed +22.7% from the comparable as-filed period.
-$32.2M→-$24.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TTAN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit increased 22.0%
Gross profit changed +22.0% from the comparable as-filed period.
$171.3M→$209.1M2 prior comparisons
Free-cash-flow margin moved 323 bp higher
Free-cash-flow margin changed +323 basis points from the comparable as-filed period.
16.20%→19.43%2 prior comparisons
Operating cash-flow margin moved 315 bp higher
Operating cash-flow margin changed +315 basis points from the comparable as-filed period.
16.66%→19.81%2 prior comparisons
Gross margin moved 64 bp higher
Gross margin changed +64 basis points from the comparable as-filed period.
70.77%→71.41%2 prior comparisons
Stock-based compensation increased 22.9%
Stock-based compensation changed +22.9% from the comparable as-filed period.
$49.3M→$60.6M2 prior comparisons
Receivables / revenue moved 244 bp higher
Receivables / revenue changed +244 basis points from the comparable as-filed period.
21.43%→23.87%2 prior comparisons
R&D / revenue moved 420 bp higher
R&D / revenue changed +420 basis points from the comparable as-filed period.
30.18%→34.37%2 prior comparisons
Working capital increased 8.0%
Working capital changed +8.0% from the comparable as-filed period.
$484.2M→$522.9M3 prior comparisons
Current assets increased 7.6%
Current assets changed +7.6% from the comparable as-filed period.
$623.0M→$670.4M3 prior comparisons
Working capital / assets moved 184 bp higher
Working capital / assets changed +184 basis points from the comparable as-filed period.
27.15%→28.98%3 prior comparisons
Capex / revenue moved 8 bp lower
Capex / revenue changed -8 basis points from the comparable as-filed period.
0.46%→0.38%2 prior comparisons
Current liabilities increased 6.3%
Current liabilities changed +6.3% from the comparable as-filed period.
$138.7M→$147.5M3 prior comparisons
Total assets increased 1.1%
Total assets changed +1.1% from the comparable as-filed period.
$1.8B→$1.8B3 prior comparisons
SBC / revenue moved 33 bp higher
SBC / revenue changed +33 basis points from the comparable as-filed period.
20.36%→20.69%2 prior comparisons
Cash & equivalents increased 1.7%
Cash & equivalents changed +1.7% from the comparable as-filed period.
$471.5M→$479.5M2 prior comparisons
Current ratio increased 1.2%
Current ratio changed +1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.49→4.553 prior comparisons
Capital expenditure decreased 0.2%
Capital expenditure changed -0.2% from the comparable as-filed period.
$1.1M→$1.1M3 prior comparisons
Operating cash-flow margin moved 617 bp higher
Operating cash-flow margin changed +617 basis points from the comparable as-filed period.
-6.76%→-0.58%2 prior comparisons
Free-cash-flow margin moved 655 bp higher
Free-cash-flow margin changed +655 basis points from the comparable as-filed period.
-7.35%→-0.80%2 prior comparisons
Stock-based compensation increased 24.7%
Stock-based compensation changed +24.7% from the comparable as-filed period.
$43.7M→$54.6M2 prior comparisons
Current liabilities increased 17.9%
Current liabilities changed +17.9% from the comparable as-filed period.
$114.8M→$135.4M2 prior comparisons
Capital expenditure decreased 53.9%
Capital expenditure changed -53.9% from the comparable as-filed period.
$1.3M→$596,0002 prior comparisons
Receivables / revenue moved 224 bp higher
Receivables / revenue changed +224 basis points from the comparable as-filed period.
21.33%→23.57%2 prior comparisons
Current assets increased 8.7%
Current assets changed +8.7% from the comparable as-filed period.
$553.0M→$600.9M2 prior comparisons
Stockholders' equity increased 7.3%
Stockholders' equity changed +7.3% from the comparable as-filed period.
$1.5B→$1.6B2 prior comparisons
Working capital increased 6.2%
Working capital changed +6.2% from the comparable as-filed period.
$438.1M→$465.5M2 prior comparisons
Capex / revenue moved 38 bp lower
Capex / revenue changed -38 basis points from the comparable as-filed period.
0.60%→0.22%2 prior comparisons
Working capital / assets moved 127 bp higher
Working capital / assets changed +127 basis points from the comparable as-filed period.
25.36%→26.64%2 prior comparisons
Current ratio decreased 7.9%
Current ratio changed -7.9% from the comparable as-filed period.
4.82→4.442 prior comparisons
Total assets increased 1.2%
Total assets changed +1.2% from the comparable as-filed period.
$1.7B→$1.7B2 prior comparisons
SBC / revenue moved 2 bp higher
SBC / revenue changed +2 basis points from the comparable as-filed period.
20.28%→20.30%2 prior comparisons
R&D / revenue moved 69 bp higher
R&D / revenue changed +69 basis points from the comparable as-filed period.
32.05%→32.74%2 prior comparisons
Cash & equivalents increased 0.3%
Cash & equivalents changed +0.3% from the comparable as-filed period.
$420.3M→$421.5M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.